Clene (CLNN) director granted 2,887 options at $7.30, vest now
Clene Inc. (CLNN) reported an insider equity award.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Clene Inc. (CLNN) reported an insider equity award. A director filed a Form 4 disclosing a stock option grant for 2,887 shares of common stock at an exercise price of $7.30 per share on November 13, 2025. The options vest immediately upon grant under the Clene Inc. Amended 2020 Stock Plan and carry an expiration date of November 12, 2035. Following the transaction, the filing shows 2,887 derivative securities beneficially owned with direct ownership.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | stock option | 2,887 | $0.00 | $0.00 |
Footnotes (1)
- F1. This option was granted on November 13, 2025 as an option for 2,887 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $7.30 per share. The options vest immediately upon grant.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Clene (CLNN) disclose in this Form 4?
When do the Clene (CLNN) options vest?
What is the expiration date of the options reported by CLNN?
Under which plan were the Clene options granted?
How many derivative securities are beneficially owned after the transaction?
What is the ownership form for the reported options?
What is the reported price of the derivative security?
AI-generated analysis. How Rhea-AI works. Not financial advice.